Hematologic adverse effects induced by piperacillin–tazobactam: a systematic review of case reports
Q Wang, Z He, X Wu, Y Wei, J Huang - International Journal of Clinical …, 2020 - Springer
Background Piperacillin/tazobactam, a semisynthetic antibiotic, is widely used to treat
polymicrobial infections. Its hematologic adverse reactions are rare and the severity can be …
polymicrobial infections. Its hematologic adverse reactions are rare and the severity can be …
The safety and efficacy of continuous tirofiban as a monoantiplatelet therapy in the management of ruptured aneurysms treated using stent-assisted coiling or flow …
BACKGROUND Hemorrhagic complications are a major concern for aneurysmal
subarachnoid hemorrhage patients treated with stenting or stent-assisted coiling and …
subarachnoid hemorrhage patients treated with stenting or stent-assisted coiling and …
Tirofiban-induced thrombocytopenia
J Wang, D Zou - Annals of Medicine, 2023 - Taylor & Francis
Tirofiban is a small non-peptide ligand-mimetic Glycoprotein (GP) IIb/IIIa inhibitor which can
reversibly bind to the arginine-glycine-aspartic acid (RGD) recognition site of GP IIb/IIIa to …
reversibly bind to the arginine-glycine-aspartic acid (RGD) recognition site of GP IIb/IIIa to …
An unusual case of drug-induced thrombocytopenia
S Wang, K Sawalha, A Khan - Journal of Investigative …, 2020 - journals.sagepub.com
Drug-induced thrombocytopenia (DIT) is a differential diagnosis for consideration when
acute thrombocytopenia is encountered in the outpatient or inpatient setting. The …
acute thrombocytopenia is encountered in the outpatient or inpatient setting. The …
[HTML][HTML] Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach
GM Jiménez-Rodríguez… - Interventional …, 2023 - ncbi.nlm.nih.gov
Abstract Glycoprotein IIb/IIIa inhibitors are an adjuvant therapy for the treatment of patients
with acute coronary syndromes. The main adverse reactions are bleeding and …
with acute coronary syndromes. The main adverse reactions are bleeding and …
Drug-induced thrombocytopenia–etiology and alternative therapeutic approaches
V Rajashekaraiah… - European Journal of …, 2023 - cejsh.icm.edu.pl
Introduction and aim. The cumulative incidence of drug-induced thrombocytopenia (DIT) is
10 cases per one million people per year with a prevalence of approximately 25% in …
10 cases per one million people per year with a prevalence of approximately 25% in …
An unusual case of clopidogrel-induced isolated severe thrombocytopenia: A fact less commonly known
I Jamal - Indian Journal of Pathology and Microbiology, 2023 - journals.lww.com
Dear Editor, Drug‑induced thrombocytopenia (DIT) is a differential diagnosis whenever an
acute episode of thrombocytopenia is encountered in patients, especially those who have …
acute episode of thrombocytopenia is encountered in patients, especially those who have …
Clinical observation and intervention analysis of patients with severe thrombocytopenia induced by tirofiban
R Jing, S Guo, Y Li - 2023 - researchsquare.com
Background There have been individual cases of successful treatment of tirofiban-induced
thrombocytopenia by immunosuppressive agents (glucocorticoids and/or immunoglobulin) …
thrombocytopenia by immunosuppressive agents (glucocorticoids and/or immunoglobulin) …
Trombocitopenia aguda grave asociada al uso de tirofiban intravenoso, posterior a intervención coronaria percutánea
GAQ Villarreal, OVV Serpa… - Revista Cubana de …, 2022 - revmie.sld.cu
Introducción: Los inhibidores de la glicoproteína IIb/IIIa son fármacos potentes en la
inhibición de la agregación plaquetaria y se administran a pacientes con síndrome …
inhibición de la agregación plaquetaria y se administran a pacientes con síndrome …